Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations

World News: . []

SALT LAKE CITY Dec 06 2018 GLOBE NEWSWIRE -- Inc NASDAQ MYGN a leader in molecular diagnostics and personalized medicine today announced results from an important study to validate the polygenic component of a forthcoming riskScore™ test f...

More news and information about Myriad Genetics, Inc.

Published By:

Globe Newswire: 13:30 GMT Thursday 6th December 2018

Published: .

Search for other references to "myriad" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us